Summary

States congressional findings about ataxia, describing it as a group of rare neurodegenerative conditions that impair coordination and movement. The legislation explains that ataxia affects people of all ages, can be inherited or caused by noninherited conditions, imposes physical, psychological, and financial burdens, and has few approved treatments or cures while clinical research continues.

• Legislation records findings that ataxia is a disorder of brain function that impairs coordination and movement.
• Ataxia affects people of all ages, including children, and includes a group of rare inherited neurodegenerative diseases.
• Each inherited ataxia meets the Orphan Drug Act definition of a rare disease (fewer than 200,000 affected in the U.S.).
• Ataxia symptoms can come from inherited genetic causes or from noninherited events and conditions (e.g., stroke, trauma, MS).
• Inheritance patterns include autosomal dominant and autosomal recessive forms.
• Ataxia causes physical, psychological, and financial burdens; many patients need assistive devices and therapy.
• There are few approved treatments and no cures for ataxia; clinical research into treatments is ongoing.
• The text documents findings only and does not authorize funding or create new federal requirements.